← Volver al catálogo
Glicoproteínas
Glyc-B
Señal de RMN de glicoproteínas de fase aguda β/γ (principalmente transferrina e inmunoglobulina G), complementaria a Glyc-A y relacionada con la respuesta inmunitaria adaptativa.
Contextos de aplicación
- Inflamación e inmunidad
Matrices contempladas
- Suero o plasma
Técnicas relacionadas
- ¹H-RMN
Publicaciones relacionadas
- Characterization of 1H NMR Plasma Glycoproteins as a New Strategy To Identify Inflammatory Patterns in Rheumatoid Arthritis. 2018 · Journal of proteome research · 72 citas
- Glycoprotein Profile Assessed by 1H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study. 2020 · Journal of clinical medicine · 22 citas
- Glycoprotein Profile Measured by a 1H-Nuclear Magnetic Resonance Based on Approach in Patients with Diabetes: A New Robust Method to Assess Inflammation. 2021 · Life (Basel, Switzerland) · 21 citas
Ver 45 más Ver menos
- Title: Human Serum/Plasma Glycoprotein Analysis by 1H-NMR, an Emerging Method of Inflammatory Assessment. 2020 · Journal of clinical medicine · 97 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Glycoprotein A and B Height-to-Width Ratios as Obesity-Independent Novel Biomarkers of Low-Grade Chronic Inflammation in Women with Polycystic Ovary Syndrome (PCOS). 2019 · Journal of proteome research · 63 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease. 2021 · Frontiers in endocrinology · 29 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. 2022 · Cardiovascular diabetology · 26 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease. 2020 · Journal of clinical medicine · 25 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- The multiomics blueprint of the individual with the most extreme lifespan. 2025 · Cell reports. Medicine · 23 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia. 2024 · Journal of lipid research · 22 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Lipidomics of triglyceride-rich lipoproteins derived from hyperlipidemic patients on inflammation. 2024 · European journal of clinical investigation · 19 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Multifaceted Analysis of Cerebrospinal Fluid and Serum from Progressive Multiple Sclerosis Patients: Potential Role of Vitamin C and Metal Ion Imbalance in the Divergence of Primary Progressive Multiple Sclerosis and Secondary Progressive Multiple Sclerosis. 2023 · Journal of proteome research · 19 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Patients With Systemic Lupus Erythematosus Show an Increased Arterial Stiffness That is Predicted by IgM Anti-β2 -Glycoprotein I and Small Dense High-Density Lipoprotein Particles. 2019 · Arthritis care & research · 18 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Acute-phase glycoprotein profile responses to different oral macronutrient challenges: Influence of sex, functional hyperandrogenism and obesity. 2021 · Clinical nutrition (Edinburgh, Scotland) · 17 citas
- Bariatric surgery decreases oxidative stress and protein glycosylation in patients with morbid obesity. 2020 · European journal of clinical investigation · 17 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder. 2021 · NPJ Parkinson's disease · 16 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Serum glycoproteins A and B assessed by 1H-NMR in familial hypercholesterolemia. 2021 · Atherosclerosis · 15 citas
- Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages. 2023 · Rheumatology (Oxford, England) · 13 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk. 2023 · International journal of molecular sciences · 13 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- GlycA and GlycB as Inflammatory Markers in Chronic Heart Failure. 2022 · The American journal of cardiology · 12 citas
- Predictive Value of the Advanced Lipoprotein Profile and Glycated Proteins on Diabetic Retinopathy. 2022 · Nutrients · 12 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Laparoscopic sleeve gastrectomy alters 1H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver disease. 2021 · Scientific reports · 12 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Similarity network fusion to identify phenotypes of small-for-gestational-age fetuses. 2023 · iScience · 10 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: The Di@bet.es study. 2023 · Diabetes research and clinical practice · 10 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Cardiac telerehabilitation with long-term follow-up reduces GlycA and improves lipoprotein particle profile: A randomised controlled trial. 2022 · International journal of cardiology · 10 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Short-term effects of gastric bypass versus sleeve gastrectomy on high LDL cholesterol: The BASALTO randomized clinical trial 2024 · Cardiovascular Diabetology · 9 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes. 2022 · Diabetes care · 8 citas
- Metabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Study. 2023 · Free radical biology & medicine · 7 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- H-NMR metabolomics identifies three distinct metabolic profiles differentially associated with cardiometabolic risk in patients with obesity in the Di@bet.es cohort. 2024 · Cardiovascular diabetology · 6 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Gradual Increase in Inflammation-Linked Glycoproteins and a Proatherogenic Lipoprotein Profile in the Early Stages of Psychosis as Characterized by 1H NMR Blood Analysis. 2023 · Journal of proteome research · 6 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Combining Dietary Intervention with Metformin Treatment Enhances Non-Alcoholic Steatohepatitis Remission in Mice Fed a High-Fat High-Sucrose Diet. 2022 · Biomolecules · 6 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study. 2025 · Cardiovascular diabetology · 5 citas
- ApoC-III proteoforms are associated with better lipid, inflammatory, and glucose profiles independent of total apoC-III. 2024 · Cardiovascular diabetology · 5 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Cardiovascular risk assessment in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease. 2024 · Medicina clinica · 5 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Evolution of Serum Acute-Phase Glycoproteins Assessed by 1H-NMR in HIV Elite Controllers. 2021 · Frontiers in immunology · 5 citas
- Multilayer metabolomic integration reveals bioenergetic disruption in Long COVID. 2026 · Journal of translational medicine · 4 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Long-term mitochondrial and metabolic impairment in lymphocytes of subjects who recovered after severe COVID-19. 2025 · Cell biology and toxicology · 4 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Comprehensive analysis of glycoprotein profiles and their association with cardiovascular disease-related microRNAs in rheumatoid arthritis, metabolic disorders, and controls. 2024 · Scientific reports · 3 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Investigating the Link between Intermediate Metabolism, Sexual Dimorphism, and Cardiac Autonomic Dysfunction in Patients with Type 1 Diabetes. 2024 · Metabolites · 2 citas · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Assessment of physical status and analysis of lipidomic and metabolomic alterations in patients with Post-COVID-19 condition. 2026 · PloS one · 1 cita · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Glycoprotein and Lipoprotein Profiles Assessed by 1H-NMR and Its Relation to Ascending Aortic Dilatation in Bicuspid Aortic Valve Disease. 2022 · Journal of clinical medicine · 1 cita · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Cardiovascular risk and metabolomic profile in adolescents: A comparative study between anorexia nervosa, normal weight, and obesity. 2026 · Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- A Robust Multivariate Approach Unveils a 1H-NMR-Based Spectral Metabolomics Signature Predictive of Cardiovascular Disease in People with Type 2 Diabetes: A Prospective Di@bet.es Cohort Study. 2025 · Journal of proteome research · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Plasma protein glycosylation: a biomarker for predicting metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease. 2025 · Revista espanola de enfermedades digestivas
- Glycoprotein Determination with NMR Spectroscopy to Evaluate the Effect of Metabolic Surgery over the Proinflammatory State of Patients with Obesity. 2025 · Obesity surgery
- Effect of early initiation of empagliflozin with or without sacubitril/valsartan in a swine model of myocardial infarction 2025 · British Journal of Surgery · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- The athero-contour: A novel tool for global and rapid assessment of atherogenic parameters. A use case in saroglitazar treatment of MAFLD patients. 2025 · Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Characterization of triglyceride rich lipoproteins and glycoproteins assessed by 1H-NMR in metabolic patients and its association with liver steatosis 2021 · Atherosclerosis · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
Actualidad relacionada
- Icosapento de etilo y riesgo cardiovascular residual: qué revela la RMN más allá de los triglicéridos 16 de septiembre de 2026 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Inflamación de bajo grado y glicoproteínas: nuevas evidencias tras la cirugía metabólica 13 de noviembre de 2025 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Liposcale and Glycoscale in Cardiovascular Risk Prediction in Type 2 Diabetes 25 March 2025 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
Ver 17 más Ver menos
- Metabolómica en el Deporte: Aplicaciones en el Rendimiento y la Recuperación 24 de octubre de 2024 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Nutrición y Salud Cardiovascular: Reflexiones en el Día Mundial de la Alimentación 16 de octubre de 2024 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Hipercolesterolemia Familiar y la Importancia de la Metabolómica para su Detección y Tratamiento Personalizado 24 de septiembre de 2024 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Papel de la Metabolómica en Enfermedades Infecciosas: Enfoque Transversal 19 de septiembre de 2024 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Desvelando Misterios de la Complejidad Lipoproteica en Diabetes Tipo 2 y Riesgo Cardiovascular 29 de abril de 2024 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Enfermedades Neurodegenerativas: La Metabolómica revela Biomarcadores para Diagnóstico Precoz 11 de abril de 2024 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Impacto de la cirugía bariátrica en la dislipidemia y la reducción del riesgo cardiovascular 02 de abril de 2024 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Estudiando la Metabolómica mediante Resonancia Magnética Nuclear y su Impacto en Intervenciones Nutricionales 13 de febrero de 2024 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Metabolómica y Salud Sexual y Reproductiva 12 de diciembre de 2023 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- ¿Qué aporta la metabolómica en la investigación contra el VIH? 30 de noviembre de 2023 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Glicoproteínas: Marcadores emergentes de inflamación 20 de noviembre de 2023 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- ¿Qué es la metabolómica y cómo se aplica en la diabetes? 13 de noviembre de 2023 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Biosfer Teslab lanza el Test MetBalance 04 de octubre de 2022 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Nuestro test de lipoproteínas y glicoproteínas presentes en la jornada de la SEA 04 de abril de 2022 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Barça Innovation Hub: La metabolómica a la vanguardia del deporte de élite 16 de noviembre de 2021 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Liposcale para el diagnóstico y el pronóstico temprano y fiable de pacientes con cáncer de mama. 07 de septiembre de 2021 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- GlycA como nuevo biomarcador en artritis reumatoide 21 de octubre de 2020 · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
Proyectos relacionados
- AVANTE 2023 · Coordinador del consorcio · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- CARDIOSCOPE 2022 · Socio del consorcio · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- COST Action AtheroNET 2022 · Socio del consorcio · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
Ver 3 más Ver menos
- VISIONING 2021 · Coinvestigador principal, con la plataforma de metabolómica del IISPV · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Torres Quevedo · Metabolómica diagnóstica 2020 · Empresa beneficiaria · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)
- Industrial Doctoral Plan Fellowship 2016 · Empresa beneficiaria · Panel: Glicoproteínas por RMN (GlycA, GlycB, GlycF)